Adult Immunization Toolkit
The AIM Adult Immunization toolkit features activities and strategies that immunization programs have employed to improve the delivery of immunizations to adults.
The AIM Adult Immunization toolkit features activities and strategies that immunization programs have employed to improve the delivery of immunizations to adults.
AIM's Vaccine Confidence Toolkit is designed to equip immunization program managers and their staff with the tools and information necessary to promote vaccine confidence across the nation and its territories.
During this Lunch & Learn conversation, iREACH Subject Matter Experts (SMEs) Yabo Beysolow, MD, and Lisa Jacques-Carroll shared updates on a range of topics related to vaccines during pregnancy, including: Vaccine recommendations Vaccination data & vaccine hesitancy report Vaccine safety…
In this webinar, Strategic Solutions Group (SSG) demonstrates their low-code platform for public health, Casetivity. During this demonstration, SSG discusses the various use cases of their Casetivity platform in immunization and will show the solution used to help onboard external…
At the state and local levels, the collaboration between immunization programs and Medicaid programs can overcome challenges and reach mutual goals.
Since the beginning of pandemic, immunization program managers have been working long days, nights, and weekends to address the many challenges of vaccinating the nation. The success and impact of this vaccine campaign are nothing short of miraculous.
This webinar offers insight into how health departments can strengthen partnerships between public information officers (PIOs), communications staff, and immunization program managers and their staff.
In this webinar, AstraZeneca shares forecasts for the upcoming influenza seasonal vaccine and expectations for routine vaccinations.
The CommuniVax Coalition has released a new report, Carrying Equity in COVID-19 Vaccination Forward: Guidance Informed by Communities of Color, to inform this work.
This talking points document was developed by iREACH Subject Matter Experts to provide information on the few cases of GBS reported in individuals who received the J & J COVID-19 vaccines.